| Journal | Drug and alcohol dependence |
| Study Type | Clinical Study |
| Population | Human participants |
This study provides critical real-world data on how Australians actually use cannabis versus intended regulatory frameworks. Understanding dual-use patterns helps clinicians recognize that many patients may be combining regulated medical cannabis with illicit recreational products, which has important safety and therapeutic implications.
This cross-sectional analysis of 3,042 Australian adults from the 2023 International Cannabis Policy Study found that among cannabis users, medical-only use represented just 1.9% of the population, while recreational-only use was 6.7% and dual-use was 5.0%. The study examined self-reported motives for cannabis use within Australia’s evolving medicinal cannabis regulatory framework. Notably, dual-use was substantial, suggesting many patients combine prescribed medical cannabis with non-medical sources. The research relied on self-reported data and cross-sectional design, limiting causal inferences about use patterns.
“What strikes me most is that dual-use nearly matches recreational-only use, suggesting our regulatory distinctions may not reflect patient reality. This reinforces my clinical experience that patients often supplement prescribed cannabis with other sources when medical access remains limited or expensive.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- What proportion of Australian adults use cannabis for medical purposes?
- Should I be concerned about patients using cannabis for both medical and recreational purposes?
- What medical conditions do patients most commonly self-treat with cannabis?
- How should I approach patients who may be using recreational cannabis for medical symptoms?
- What does this data mean for medical cannabis prescribing practices in Australia?
FAQ
What proportion of Australian adults use cannabis for medical purposes?
According to this 2023 study, only 1.9% of Australian adults reported using cannabis exclusively for medical purposes, while 5.0% reported dual-use (both medical and recreational). This suggests that pure medical cannabis use remains relatively uncommon in the general population despite Australia’s expanding medicinal cannabis framework.
Should I be concerned about patients using cannabis for both medical and recreational purposes?
Dual-use cannabis consumption affects 5.0% of Australian adults and represents a significant portion of medical cannabis users. Clinicians should discuss this openly with patients as dual-use may affect dosing, therapeutic outcomes, and legal compliance with prescribed medical cannabis regimens.
What medical conditions do patients most commonly self-treat with cannabis?
While the study summary indicates that specific medical conditions were identified as the most frequently cited indications, the complete data on these conditions is not provided in the available excerpt. Clinicians should inquire about self-medication practices when evaluating patients for conditions commonly associated with cannabis use, such as chronic pain, anxiety, and sleep disorders.
How should I approach patients who may be using recreational cannabis for medical symptoms?
Given that recreational-only use (6.7%) exceeds medical-only use (1.9%), some patients may be self-medicating with illicit cannabis rather than accessing legal medical cannabis. Consider screening for underlying medical conditions and discussing legal medical cannabis options when appropriate.
What does this data mean for medical cannabis prescribing practices in Australia?
The relatively low rate of medical-only cannabis use (1.9%) compared to recreational and dual-use suggests potential barriers to accessing legal medical cannabis or patient preferences for non-medical sources. This highlights the importance of understanding patient cannabis use patterns and addressing access barriers in clinical practice.
